Biogen Inc (NASDAQ:BIIB)
| 267.12 BATS BZX Real-Time Price As of 1:58pm ET |  -3.02 / -1.12%Today’s Change | 223.25 Today|||52-Week Range 363.92 | +9.09% Year-to-Date |
Latest BIIB News | Press Releases
Today’s Trading
| Previous close | 270.14 |
| Today’s open | 270.09 |
| Day’s range | 265.46 - 270.77 |
| Volume | 38,427 |
| Average volume (3 months) | 1,247,487 |
| Market cap | $41.2B |
Data as of 1:58pm ET, 04/19/2021
Growth & Valuation
| Earnings growth (last year) | -21.00% |
| Earnings growth (this year) | -45.30% |
| Earnings growth (next 5 years) | -5.14% |
| Revenue growth (last year) | -2.82% |
| P/E ratio | 10.8 |
| Price/Sales | 3.20 |
| Price/Book | 3.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | +5.17 | +1.30% |
| EXASExact Sciences Corp | -4.15 | -3.19% |
| ---- | ||
| NVAXNovavax Inc | -0.74 | -0.33% |
Data as of 2:00pm ET, 04/19/2021
Financials
| Next reporting date | April 22, 2021 |
| EPS forecast (this quarter) | $5.01 |
| Annual revenue (last year) | $12.4B |
| Annual profit (last year) | $4.0B |
| Net profit margin | 32.38% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
